Carlsmed (CARL) Enterprise Value (2025 - 2026)

Carlsmed's (CARL) quarterly Enterprise Value came in at $169.3 million in Q2 2026, up 35.56% quarter-over-quarter from $124.9 million in Q1 2026.

Analysis

Carlsmed (CARL) Enterprise Value (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has reported Enterprise Value for 2 consecutive years, with $169.3 million the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Enterprise Value changed N/A year-over-year to $169.3 million; the trailing twelve-month figure through Jun 2026 stood at $169.3 million (changed N/A YoY), and the FY2025 full-year result was $65.8 million, changed N/A from the prior year.
Enterprise Value grew to $169.3 million in Q2 2026 per CARL's latest filing, from $124.9 million in the prior quarter.
Across five years, Enterprise Value topped out at $169.3 million in Q2 2026 and bottomed at $65.8 million in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn
10	Carlsmed	424.72 Mn	311.42 Mn	14.54 Mn

Historic Data

Download Data